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Abstract
Background: Intestinal mucosa is leaky in celiac disease (CD), and this alteration may involve changes in
hydrophobicity of the mucus surface barrier in addition to alteration of the epithelial barrier. The aims of our study
were i) to compare duodenal hydrophobicity as an index of mucus barrier integrity in CD patients studied before
(n = 38) and during gluten- free diet (GFD, n = 68), and in control subjects (n = 90), and ii) to check for regional
differences of hydrophobicity in the gastro-intestinal tract.
Methods: Hydrophobicity was assessed by measurement of contact angle (CA) (Rame Hart 100/10 goniometer)
generated by a drop of water placed on intestinal mucosal biopsies.
Results: CA (mean ± SD) of distal duodenum was significantly lower in CD patients (56° ± 10°)) than in control
subjects (69° ± 9°, p < 0.0001), and persisted abnormal in patients studied during gluten free diet (56° ± 9°; p <
0.005). CA was significantly higher (62° ± 9°) in histologically normal duodenal biopsies than in biopsies with Marsh
1-2 (58° ± 10°; p < 0.02) and Marsh 3 lesions (57° ± 10°; p < 0.02) in pooled results of all patients and controls
studied. The order of hydrofobicity along the gastrointestinal tract in control subjects follows the pattern: gastric
antrum > corpus > rectum > duodenum > oesophagus > ileum.
Conclusions: We conclude that the hydrophobicity of duodenal mucous layer is reduced in CD patients, and that
the resulting decreased capacity to repel luminal contents may contribute to the increased intestinal permeability
of CD. This alteration mirrors the severity of the mucosal lesions and is not completely reverted by gluten-free diet.
Intestinal hydrophobicity exhibits regional differences in the human intestinal tract.
Background
The intestinal barrier is an important defence mechan-
ism to prevent the spreading of bacteria and toxins of
different origin from intestinal lumen to the systemic
circulation [1]. It consists of the epithelial barrier, an
anatomical barrier between the luminal content and the
host, and of the pre-epithelial barrier, a functional bar-
rier mainly constituted of a mucus layer and by other
factors such as the trefoil peptides, defensins and secre-
tory IgA. The importance of the mucus layer as a com-
ponent of the pre-epithelial barrier is supported by a
large body of evidence in humans and in the animal in
studies showing a protective effect against injury in the
stomach [2,3], and a capacity to prevent bacteria and
luminal toxins to come into direct contact with intest-
inal epithelium [4].
The intestinal barrier is altered in several diseases
including celiac disease (CD) [5] an autoimmune disease
that develops in genetically predisposed subjects exposed
to ingestion of wheat gliadin and of related prolamines
of barley and rye. This alteration of the intestinal barrier
of CD results in increased intestinal permeability [6], a
phenomenon attributed to excess production of a local
peptide, zonulin, leading to disassembly of the tight
junction structure that in physiological conditions seals
the barrier and limits the paracellular passage of
* Correspondence: lanzini@med.unibs.it
1Gastroenterology Unit: Spedali Civili and University. Piazzale Spedali Civili 1.
25123 Brescia. Italy
Full list of author information is available at the end of the article
Bertolazzi et al. BMC Gastroenterology 2011, 11:119
http://www.biomedcentral.com/1471-230X/11/119
© 2011 Bertolazzi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
macromolecules, including the toxic fractions of gliadin
[7]. This pathogenetic mechanism and the subsequent
sub-epithelial events leading to intraepithelial lymphocy-
tic infiltration and to mucosal atrophy have been exten-
sively studied [8], but limited information is available on
events involving the pre-epithelial component of the
intestinal barrier, namely the mucous layer.
One way of assessing the functional integrity of the
mucus layer is by measuring its hydrophobicity, a sur-
face bio-physical property that affects adhesion of
macromolecules, bacteria and toxins to the intestinal
epithelia [9,10]. The importance of this characteristic in
contributing to the integrity of the intestinal barrier is
supported by the finding that decreased hydrophobicity
has been documented in a variety of conditions includ-
ing peptic ulcer disease [11], Helicobacter pylori infec-
tion and gastritis [12], and to accompany damage to the
stomach or colon caused by non steroidal anti-inflam-
matory drugs [13], 2,4,6-trinitrobenzenesulphoric acid
[14], LPS [15] or dextran sodium sulphate [16].
Mucosal hydrophobicity can be assessed by an empiri-
cal thermodinamic approach involving measurement of
the contact angle subtended at the triple point where
the solid-liquid, liquid-air and solid air interfaces meet
following application of a drop of fluid to a solid surface
[2]. The principle behind this technique is that a drop
of fluid tend to form beads when applied on hydropho-
bic surfaces forming high contact angles at the triple
point interface, and to spread on hydrophilic surfaces
forming a small contact angle. Thus the higher is the
contact angle the more hydrophobic is the surface.
The aim of our study was to assess the hyfrophobicity
of the mucus barrier by measuring contact angle of gas-
tro-intestinal mucosa exposed to a drop of saline in CD
patients at diagnosis, and to assess the effect of gluten
free diet (GFD). We also studied control subjects to
obtain reference values of surface hydrophobicity of dif-
ferent regions of the gastro-intestinal tract in healthy
humans. Preliminary validation studies were carried out
to assess optimal experimental conditions and
reproducibility.
Methods
We collected mucosal biopsies at endoscopy in 3 differ-
ent groups of patients consecutively recruited from
December 2004 to January 2007. The first group con-
sisted of control subjects referred to our Gastroenterol-
ogy Unit for clinical and endoscopic evaluation. In all
cases no abnormality was detected at endoscopy or his-
tology except for minimal changes, and in all cases the
final diagnosis was of functional disease. The second
group consisted of CD patients diagnosed on the basis
of positive anti- t-transglutaminases and/or antiendomy-
sial antibodies and of a characteristic duodenal lesion.
The third group consisted of CD patients on GFD for at
least 1 year undergoing follow-up endoscopy, a standard
procedure in our CD Clinic [17]. In these latter group
adherence to GFD was assessed by interview using a 4
point Likert scale as previously described [18].
Following endoscopic examination biopsy specimens
were taken 1 cm above the Z line in the oesophagous, 1
cm above the lesser curve and within 2 cm of the
pylorus in the stomach, and at midway along the des-
cending duodenum. Biopsies in the rectum were col-
lected at 10 cm from the anal verge, and in the terminal
ileum at 5 cm from the ileo-cecal valve. Biopsies were
placed mucosal up on a piece of cellulose disk, and 1
unfixed biopsy specimen from each region was used for
measurement of mucosal hydrophobicity by goniometry.
Two more biopsies (4 in the case of duodenal biopsies)
were fixed with formalin for subsequent histological
examination.
Sections for histological examination were stained
with H&E and presence and severity of inflammation
was graded according to standard criteria. Duodenal
biopsies have been graded according to modified Marsh
classification [19,20], and immnuohistochemistry has
been used to identify and count CD3+ intraepithelial
lymphocytes.
For goniometry, freshly collected biopsy specimens
oriented mucosal up were immediately washed with sal-
ine and placed on the stage of the goniometer (Rame/
Hart 100/00 NJ, USA) fitted with a monochromatic light
source and micrometer-activated syringe (Rame-Hart
100-10) for applying 5 μL of 0.15 M saline to the biopsy
surface [21]. On application of the water drop two
cross-hairs fitted within the microscope of the goni-
ometer were aligned to the tangent of the air-saline
drop-biopsy interface and the contact angle read off a
scale incorporated in the eyepiece of the goniometer. All
goniometric measurements have been carried out by
one of us (SB) unaware of the site of biopsies and of
endoscopic findings. The value of each measurement
was the mean of 3 contact angle readings.
Validation studies
The effect of drying of mucosal biopsies on CA mea-
surements was assessed by allowing biopsies to air dry
at room temperature after gentle washing, and by mea-
suring contact angle at 10 min intervals starting from 10
minutes after collection. Reproducibility of CA measure-
ments by the same goniometrist was assessed by calcu-
lating coefficient of variation of multiple measurements
on biopsy specimens.
Statistics
Results are expressed as means ± SD and as upper and
lower 95% Confidence Interval of the mean. Unpaired t
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test was carried out for comparisons, and a p value <
0.05 was taken to indicate statistical significance for
differences.
The study has been carried out in compliance with the
Helsinki Declaration following approval by our Institu-
tional Ethics Committee, and patients have signed an
informed consent to the study.
Results
Thirty-eight newly diagnosed CD patients on gluten
containing diet, 68 CD patients on GFD and 105 con-
trols (69 for upper and 36 for both upper and lower gas-
trointestinal tract studies) participated to the study.
Anthropometric, serological and histological characteris-
tics of patients and controls are summarized in table 1.
All CD patients studied on gluten containing diet tested
positive at CD related serology, and duodenal biopsy
showed villous atrophy in 33 and lymphocytic duodeno-
sis in 5. All patients studied on GFD given for 29 ± 10
months (range 12-35 months) were strictly adherent to
GFD as assessed by interview, and all tested negative at
CD related serology. Duodenal histology demonstrated
persistent lymphocytic duodenosis in 60 patients, and
mild villous atrophy in 5. No one of the control subjects
tested positive at anti- t-transglutaminases antibodies
serological screening.
Validation studies (figure 1)
The effect of mucosal drying on goniometric measure-
ments was studied in 15 gastric, 12 duodenal and 12
Table 1 anthropometric and clinical characteristics of
celiac patients studied at baseline, of patients studied
during gluten free diet and of control subjects
Upper GI tract Celiacs Controls
Baseline GFD
n 38 68 69
F/M 27/11 49/19 50/19
age (years) 34.5 ± 4.7 36.2 ± 2.2 48.9 ± 16.4*
Marsh
0 0 2 57
1 0 0 3
2 5 60 8
3a 5 5 0
3b 5 1 0
3c 23 0 0
Antibodies (n)
tTg 17 0 0
EMA 13 0 0
t-TG + EMA 8 0 0
HP (n)
positive 8 10 13
negative 30 58 56
Upper and lower GI tract Controls
n 36
F/M 21/15
age (years) 51.6 ± 20.5*
Biopsies of the lower gastrointestinal tract have been obtained in control
subjects only. GFD = gluten free diet GI = gastrointestinal. * = p < 0.0001
Figure 1 Validation study: effect of mucosal drying on gastric,
duodenal and rectal mucosal contact angle.
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rectal biopsies. Contact angle increased in gastric biop-
sies from 59° ± 4° at time 10 minutes to 72° ± 4° at time
20 minutes and remained stable thereafter at time 30
(68° ± 3°), 40 (72° ± 4°), 50 (70° ± 3°) and 60 minutes
(67° ± 3°). Similar pattern with early increase in value
and a plateau effect after 20 minutes was observed for
biopsies taken in the duodenum (53° ± 2°, 64° ± 3°, 65°
± 2°, 65° ± 2°, 61° ± 2° and 61° ± 2° at time 10, 20, 30,
40 50 and 60 minutes respectively) and in the rectum
(57° ± 3°, 69° ± 3°, 70° ± 2°, 71° ± 4°, 69° ± 3° and 69° ±
4° at time 10, 20, 30, 40 50 and 60 minutes respectively).
Coefficient of variation for 5 CA readings in 6 biopsy
specimens of gastric corpus was 8%, 3%, 5%, 2%,2% and
5%, respectively.
Based on these validation results all subsequent mea-
surements of contact angle were carried on mucosal
biopsies within 20-60 min from collection following
gentle biopsy washing with saline.
Surface hydrophobicity in celiac disease and effect of
gluten free diet (figures 2, 3)
Contact angle of duodenal biopsies (Figure 2) was signif-
icantly lower in CD patients (56° ± 10°: 95% CI: 53°-60°)
than in healthy subjects (65° ± 7°: 95% CI: 63°-67°: p <
0.0001), and remained virtually unchanged in CD
patients during GFD 56° ± 9° (95% CI: 54°-59°; p =
0.904). Contact angle of duodenal mucosa was not
affected by Helicobacter pylori infection in CD patients
(57° ± 10° vs 52° ± 11°), CD patients on GFD (57° ± 9°
vs 55° ± 9°) and controls (61° ± 10° vs 65° ± 10° for
Helicobacter pylori negative and positive, respectively)
and was not related to gender or age in all 3 groups
(Pearsons’ r = 0.02781 for CD, r = 0.1157 for CD on
GFD and r = 0.0883 for controls).
By contrast with results in duodenal biopsies, there
was no difference in contact angle measurements on
antral biopsies between CD patients (69° ± 9°; 95% CI:
65°-72°), CD patients during GFD (68° ± 10°; 95% CI:
66°-71°) and control subjects 72° ± 8° (95% CI: 70°-73°),
and there was also no difference on biopsies taken from
gastric corpus the 3 groups (70° ± 9°; 95% CI: 68°-71°//
67° ± 10°; 95% CI: 63°-71°//67° ± 10°; 95% CI: 65°-70°,
respectively).
Figure 3 shows results of contact angle measured on
duodenal mucosa plotted independently of clinical diag-
nosis as a function of histopathologic characteristics of
the mucosa in all 175 patients in the 3 groups involved
in the study. Contact angle was higher in mucosal biop-
sies classified as Marsh 0 (62° ± 9°; 95% CI: 60°-64°: p <
0.0001) than in those classified as Marsh 1-2 (58° ± 10°;
95% CI: 55°-60°: p = 0.0189) and as Marsh 3 (57° ± 10°;
95% CI: 54°-60°: p = 0.0155).
Regional differences in surface hydrophobicity (figures 4
and 5)
Regional differences for CA measurement were present
along the gastro-intestinal tract in control subjects (Fig-
ure 4). CA was 51° ± 11° (95% CI: 45° -50°) in 67 oeso-
phageal, 70° ± 9° (95% CI: 68° -71°) in 90 gastric body,
Figure 2 Contact angle of duodenal mucosa in control
subjects, celiac patients and celiac patients on gluten-free-diet
GFD = gluten free diet.
Figure 3 Contact angle of duodenal mucosa plotted according
to histopathologic classification (Marsh grade [19]) of duodenal
specimens in all patients and controls studied.
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72° ± 8° (95% CI: 70°- 73°) in 78 gastric antrum, 62° ±
10° (95% CI: 60°- 65°) in 69 duodenal, 49° ± 9° (95% CI
45° -52°) in 26 distal ileum and 66° ± 10° (95% CI: 63°
-69°) in 36 rectal biopsies.
Regional differences for CA measurement were main-
tained in CD patients in studies limited to the upper
gastro-intestinal tract (Figure 5). CA was lower on oeso-
phageal (40° ± 7° (95% CI: 37°-43°) than on gastric antral
biopsies (69° ± 9° (95% CI: 65°-72°). CA of duodenal
biopsies (56° ± 10° (95% CI: 53°-60°) was lower than that
of gastric antral 69° ± 9° (95% CI: 65°-72°: p < 0.0001)
and corpal biopsies 56° ± 10° (95% CI: 53°-60°: p <
0.0001). Similar results have been obtained in CD
patients during GFD with lower values for contact angle
in duodenal 56° ± 9° (95% CI: 54°-59°) than in gastric
antral 69° ± 10° (95% CI: 66°-71°: p < 0.0001 and corpal
biopsies 67° ± 10° (95% CI: 65°-70°: p < 0.0001).
Discussion
In the present study we assessed surface hydrophobicity
of gastrointestinal mucosa as an index of the functional
integrity of the mucus layer, a layer that acts as a
“closing seal”[22] of the intestinal barrier. This bio-phy-
sical characteristic can be studied by measuring contact
angles formed by sessile water droplets placed on freshly
collected biopsies. The interrelation between contact
angle and surface energy assumes that the surface on
which contact angle is measured is smooth and homo-
genous [23], and this is obviously not the case for
mucosal biopsies. Furthermore, drying, presence of deb-
ris and trauma of biopsy collection may cause non-phy-
siological changes. Although these observations are a
matter of concern, drying has been reported by Hills
[24] to provide a more conservative estimate of the
energy reduction that would occur if the mucus
remained in the physiological hydrated state. Our valida-
tion study confirms that contact angle increases during
mucosal drying to a point when it remains stable and
reproducible up to at least 60 min following biopsy
collection.
The main aspect of our study is that we assessed the
hydrophobicity of the duodenal mucus barrier in CD
patients studied at diagnosis and in CD patients on
GFD. This assessment was prompted by a large body of
Figure 4 Mucosal contact angle at different locations in the gastro-intestinal tract of control subjects.
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evidence indicating that intestinal permeability to
macromolecules is increased in CD patients [6,25,26].
This phenomenon has been extensively studied in rela-
tion to the epithelial component of the intestinal barrier,
and shown to involve altered regulation of the tight
junctions that provide contiguity of epithelial cells and
regulate the traffic trough the paracellular pathway.
Zonulin has been identified as a protein with capacity to
disassemble TJ [7] as an early event in the development
of CD [27] favouring the passage of gliadin toxic frag-
ments via the paracellular pathway from the intestinal
lumen to the submucosa. Although the validity of this
model has been questioned [28], the pathogenetic role
of increased permeability in development of CD is firmly
established.
Our study clearly indicates that the mucus barrier is
altered in CD, and that this defect is not restored to nor-
mal during GFD as indicated by the observation that
hdyrophobicity of duodenal mucosa is lower in CD
patients than in control subjects, and that this abnormal-
ity persists during GFD. These differences cannot be
accounted by artefacts due to Helicobacter pylori infec-
tion and by differences in age, as reported by others for
gastric biopsies [29], because there was no relationship in
our patients and in controls between these parameters
and duodenal CA. Furthermore, the younger age of our
CD compared with controls should point, if anything, to
a higher CA, an opposite effect of what we have found.
The reduced hydrophobicity is specific for duodenal
mucosa in CD, as indicated by the finding that hydro-
phobicity of gastric mucosa was similar in CD patients
and in controls.
The mechanism involved in this bio-physical altera-
tion of the duodenal mucus barrier is unclear. Previous
studies have reported alteration of the structure of
duodenal mucus in CD patients associated with defect
of the trefoil factors family [30] and with the structure
and secretory pattern of mucus glycoprotein [31],
defects that may affect stability of mucus. We could
not further investigate the mechanism involved in
reduced hydrophobicity of duodenal mucus barrier, but
it is clear from our results a relationship with the ana-
tomical changes of the mucosa, independently of clini-
cal diagnosis. This is suggested by our finding that by
plotting together results of duodenal CA obtained in
control subjects with those obtained in CD patients off
and on GFD, there was a clear-cut dependency of
reduced mucus hydrophobicity on severity of duodenal
histopathology (Figure 3). This was irrespective of clin-
ical diagnosis because the group with normal histology
comprised CD patients on GFD in addition to control
subjects, and the group with Marsh-1-2 lesion com-
prised normal subjects in addition to CD patient on or
off GFD. On the basis of our results we cannot firmly
establish the nature of this relationship, and although a
cause-effect mechanism cannot be proven it seems to
Figure 5 Mucosal contact angle at different locations in the gastro-intestinal tract of celiac patients.
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us plausible because of the independence of the aetiol-
ogy of mucosal damage.
To what extent the alteration in mucus barrier contri-
butes to the pathogenesis of CD, and whether this
alteration is a primary defect is totally unclear but it fits
a paradigm for initiation of autoimmune diseases pro-
posed by Arrieta et al [5]. According to this model,
undigested gliadin fractions are kept separate from sub-
epithelial immune system by a competent intestinal bar-
rier. Disease activation occurs when factors with capa-
city of altering the intestinal barrier integrity favour
paracellular transit of toxic fractions of gliadin, and
these initiating factors include drugs such as NSAIDs or
infections that are all well known factors for their capa-
city to disrupt the mucus barrier [13,32,33]. The late
onset of CD in genetically predisposed subjects fits with
this hypothesis on the role of initiating factors.
Another aspect of our study is that we looked at
regional differences of hydrophobicity of intestinal
mucosa in controls and in CD, and found marked differ-
ences in different intestinal regions. These differences
are qualitatively similar to those reported by Spychal et
al [21] in humans showing high hydrophobicity in gas-
tric and in rectal mucosa, with lower values in the duo-
denum and in the ileum. This regional difference is
common to many mammalian species [10,16,21,34,35]
although slight species-related differences occur. By con-
trast with results in the animal, in our study mucosal
hydrophobicity was lower in the distal ileum than in the
duodenum. No other study to our knowledge has
reported results for hydrophobicity of distal ileum in
humans, but the tendency for hydrophobicity to be
reduced from proximal to distal duodenum reported by
Spychal [21] in healthy subjects is consistent with our
results. The low hydrophobicity in the oesophagus
observed in our study is also novel, and explains the
susceptibility of oesophageal mucosa to refluxed gastric
acid because hydrophobicity is important in repelling
the diffusion of hydrogenions [2] from coming in con-
tact with the epithelial cells.
Conclusions
In conclusion our study has provided evidence that the
mucus barrier, an important component of the pre-
epithelial barrier, is altered in CD patients. We speculate
that the resulting decreased capacity of the mucus bar-
rier to repel luminal contents because of low hydropho-
bicity and to act as a “closing seal”[22] may potentially
contribute to the increased intestinal permeability char-
acteristic of CD. Although the model of intestinal
hydrophobicity as a “closing seal” has as yet to be pro-
ven, it has been proven that this bio-physical property
represents a valid criterion for assessing the protective
function of the mucus layer. Studies in the animal and
pilot studies in humans suggest that mucus layer hydro-
phobicity can be increased by oral administration of
phospholipids [36], and this may prove of value as adju-
vant treatment in CD patients with incomplete response
to GFD. Our study has also confirmed regional differ-
ences in surface hydrophobicity of the mucus layer of
control subjects, and has provided reference values that
may be of value for further comparative studies in dis-
ease conditions other than CD.
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